Veradigm Debt to Equity Ratio 2010-2022 | MDRX

Current and historical debt to equity ratio values for Veradigm (MDRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Veradigm debt/equity for the three months ending December 31, 2022 was 0.00.
Veradigm Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-12-31 $0.49B $1.02B 0.48
2022-09-30 $0.51B $1.18B 0.44
2022-06-30 $0.52B $1.20B 0.43
2022-03-31 $1.08B $1.35B 0.80
2021-12-31 $0.95B $1.36B 0.70
2021-09-30 $1.07B $1.42B 0.75
2021-06-30 $1.15B $1.39B 0.82
2021-03-31 $1.19B $1.68B 0.71
2020-12-31 $1.25B $1.67B 0.75
2020-09-30 $1.94B $1.21B 1.60
2020-06-30 $1.95B $1.24B 1.57
2020-03-31 $2.01B $1.24B 1.62
2019-12-31 $1.92B $1.29B 1.49
2019-09-30 $1.95B $1.28B 1.52
2019-06-30 $1.92B $1.32B 1.46
2019-03-31 $1.79B $1.46B 1.23
2018-12-31 $1.60B $1.58B 1.01
2018-09-30 $3.40B $1.12B 3.05
2018-06-30 $3.21B $1.14B 2.81
2018-03-31 $3.26B $1.11B 2.94
2017-12-31 $3.07B $1.16B 2.65
2017-09-30 $2.74B $1.15B 2.39
2017-06-30 $2.62B $1.17B 2.25
2017-03-31 $2.61B $1.19B 2.20
2016-12-31 $2.56B $1.27B 2.01
2016-09-30 $2.44B $1.37B 1.78
2016-06-30 $2.36B $1.35B 1.75
2016-03-31 $1.24B $1.39B 0.89
2015-12-31 $1.26B $1.42B 0.89
2015-09-30 $1.28B $1.40B 0.92
2015-06-30 $1.31B $1.39B 0.94
2015-03-31 $1.23B $1.28B 0.96
2014-12-31 $1.18B $1.28B 0.92
2014-09-30 $1.29B $1.28B 1.00
2014-06-30 $1.29B $1.30B 1.00
2014-03-31 $1.33B $1.31B 1.02
2013-12-31 $1.30B $1.32B 0.99
2013-09-30 $1.31B $1.33B 0.98
2013-06-30 $1.31B $1.37B 0.96
2013-03-31 $1.29B $1.33B 0.97
2012-12-31 $1.07B $1.28B 0.83
2012-09-30 $1.11B $1.30B 0.85
2012-06-30 $1.20B $1.28B 0.94
2012-03-31 $1.06B $1.49B 0.71
2011-12-31 $1.03B $1.48B 0.70
2011-09-30 $0.99B $1.44B 0.69
2011-06-30 $1.04B $1.41B 0.74
2011-03-31 $1.02B $1.43B 0.71
2010-12-31 $1.04B $1.38B 0.75
2010-09-30 $1.01B $1.37B 0.74
2010-06-30 $0.00B 0.00
2010-05-31 $0.29B $0.81B 0.36
2010-03-31 $0.00B 0.00
2010-02-28 $0.24B $0.79B 0.31
2009-12-31 $0.21B $0.77B 0.27
2009-11-30 $0.21B $0.77B 0.27
2009-09-30 $0.00B 0.00
2009-08-31 $0.23B $0.74B 0.31
2009-05-31 $0.25B $0.70B 0.36
2009-02-28 $0.26B $0.72B 0.36
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.482B $0.588B
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00